Baltimore-based Cerecor has gathered up the first half of a $33 million B round, with plans to devote much of that money to a midstage development program for an experimental depression therapy recently punted by a restructuring Merck.

…read more

Source: Cerecor raises $16M for PhII study of ‘Special K’ depression remedy


0 No comments